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Abstract
Aim to investigate whether the cellular uptake of cargo proteins can be enhanced by fusing a Tat peptide in the center of proteins, GST-Tat-GFP and GST-GFP-Tat proteins were firstly constructed and expressed. The cellular internalization of both proteins was then evaluated and compared in HeLa cells by using fluorescent microscopy and flow cytometry, as well as the transdermal delivery of GST-Tat-GFP in human skin by using confocal microscopy. Results from in-vitro cell experiments showed that GST-Tat-GFP protein efficiently internalized into HeLa cells when a Tat peptide was fused in the center of proteins, whereas its efficiency is lower than that of GST-GFP-Tat protein with a Tat peptide terminal fused. Ex-vivo transdermal delivery data also demonstrated that the lower efficiency of GST-Tat-GFP penetrating through human SC layer when compared with GST-GFP-Tat. Furthermore, both GST-GFP-Tat and GST-Tat-GFP presented a various degree of a mixture of cytoplasmic diffuse staining and punctate surface staining, and that the pattern of distribution varied considerably in HeLa cells experiments depending on the concentration of protein used. Therefore, an improved mechanism for Tat-conjugated proteins was proposed, in which Tat-conjugated proteins were first associated with cell membrane, then accumulated on the cell surface, and finally internalized into cells by pore formation mechanism. 

1.	Introduction
As most diseases are related to the malfunctioning or missing of proteins to a certain extent, protein therapy is therefore considered as the most direct and safe approach for diseases treatment [1,2]. However, the massive use of protein therapy in clinical practice has been limited by low permeability of cell membrane and poor stability against proteases in the cell. Several protein delivery systems have been developed to overcome these limitations, such as liposomes, microspheres, microinjection, nanocapsules and adenovirus vectors etc. Few of these methods have been widely applied in clinical practice, due to their obvious drawbacks such as inefficient membrane translocation, low bioavailability, short half-life and cellular toxicity [3-7]. 
Recently, a group of short amphipathic or polycationic sequences, so-called cell penetrating peptides (CPPs), has attracted much attention, because of their remarkable capacity for membrane translocation with high efficiency, low immunogenicity and no toxicity [8,9]. Therefore, they are regarded as one of the most promising strategies for non-invasive delivery of biomolecules into cells. The human immunodeficiency virus type 1 (HIV-1) Tat peptide (47YGRKKRRQRRR57) is one of best characterized CPPs, which contains six arginine and two lysine residues [10]. 
Although numerous experimental studies have demonstrated that Tat peptide successfully transported a wide variety of biomolecules into cells, including oligonucleotide, DNA, siRNA, peptides and proteins as well as liposomes, the detailed mechanism of internalization of Tat peptide and Tat-conjugated constructs remains unclear [11-14]. Accumulating evidences are supporting that both direct translocation and endocytosis mechanism are involved, depending on the CPP sequence, the cargo molecule and cell type [15, 16]. It is also unknown that whether cargo protein has influence on the cellular internalization and distribution of Tat peptides, especially when the cargo proteins are fused on both ends of Tat peptide. Very few studies so far have reported the cellular internalization of cargo proteins with a Tat peptide fusing in the center of proteins, while Tat peptide is normally fused to the C-terminus or N-terminus of protein in most of previous studies [17-19]. To figure out whether the cellular internalization of cargo proteins was successful when fusing a Tat peptide in the center of proteins, we chose green fluorescent protein (GFP) as a cargo protein. The characteristic properties of GFP make itself a perfect candidate as a fluorescence reporter to monitor patterns of protein localization, and intracellular protein trafficking in vivo [20-22].
The aim of this study is to investigate whether the cellular internalization of recombinant proteins can be successfully enhanced by fusing a Tat peptide in the center of proteins, providing supplementary supports for our previous assumption on the pore formation mechanism of Tat peptide and Tat-conjugated proteins. Two recombinant proteins GST-Tat-GFP and GST-GFP-Tat were constructed and expressed. Then their efficacy of cellular internalization in HeLa cells was evaluated and compared, as well as the transdermal delivery in human skin. 

2. Materials and Methods
2.1. Chemicals
Yeast extract and tryptone were purchased from OXOID (Hampshire, England). All other chemicals used in this study were of analytical grade commercially available. Isopropylthio-D-galactoside (IPTG)，X-gal, ampicillin, EDTA, thrombin, Trypsin 1:250, Hepes (free acid), RPMI1640 Medium and fetal bovine serum (FBS) were purchased from Sigma. The glutathione-sepharose 4B (GS-4B) affinity resin was purchased from GE Healthcare (USA).

2.2. Strains, plasmids and enzymes 
Escherichia coli strain BL21 was purchased from Novagen, USA. pGEX-2T vector was purchased from GE Healthcare, USA. Restriction enzymes and DNA extraction kit were purchased from Shanghai Sangon, China. 

2.3. pGEX-GFP, pGEX-GFP-Tat and pGEX-Tat-GFP plasmids 
pGEX-GFP, pGEX-GFP-Tat and pGEX-Tat-GFP protein expression vectors were a generous gift from Dr. Maruro Giacca and Dr. Antonio Fittipaldi (Molecular medicine laboratory, International center for genetic engineering and biotechnology, Trieste, Italy). The sequence of Tat was TATGGCAGGAAGAAGCGGAGACAGCGACGAAGA. The above plasmids were transformed into E coli BL21. The clones with the expected insert were selected using BamHI-EcoRI restriction analysis and then analysis of DNA sequencing.

2.4 Protein expression and affinity chromatography purification
The transforms were grown in TB broth (12 g/L Tryptone, 24 g/L Yeast Extract, 4 g/L Glycerol, 2.1 g/L KH2PO4, 14.7 g/L K2HPO4) overnight with 100 mg/L ampicillin at 30 ℃. The 10% inoculation was cultured at 25℃ with vigorous shaking. The protein expression was induced with 0.5 mmol/L IPTG when OD600 was around 1.0. After induction for 5 h, cells were harvested by centrifugation at 4000rpm at 4 ℃ for 10 min. The supernatant was discarded and the pellet was resuspended in sonication buffer (50 mmol/L Tris-HCl, pH 8.0, 50g/L glycerol, 150 mmol/L NaCl,), and the cells were sonicated in icy bath for 15 min. The lysed cells were centrifuged at 12000 rpm, 4 ℃ for 5 minutes and the pellets were discarded. 
The supernatant was applied to 2ml glutathione-sepharose 4B (GS-4B) affinity resins and washed with Buffer A (50 mmol/L Tris-HCl, pH 8.0, 150 mmol/L NaCl). The bound protein was subsequently eluted with 10 mM reduced glutathione in Buffer A and the eluate was collected. The protein concentrations were quantified by a Foline-phenol analysis, using bovine serum albumin (BSA) as the standard. The purified recombinant proteins were dissolved in PBS and stored at -80℃.

2.5 Gel Electrophoresis
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) was carried out according to the method of Laemmli using 12.5% polyacrylamide gel (Laemmli, 1970). Protein bands were visualized by Coomassie Brilliant Blue R-250 staining. The following proteins were used as SDS–PAGE electrophoresis molecular weight standards: rabbit phosphorylase b (97.4 kDa), bovine serum albumin (66.2 kDa), rabbit actin (43 kDa), bovine carbonic anhydrase (31 kDa), trypsin inhibitor (20.1 kDa), and hen egg white lysozyme (14.4-kDa).

2.6 Western blotting analysis 
Expression of all constructs was confirmed by western blotting. Cell lysates were prepared was performed in a buffer containing 1% Triton X-100, 50 mM HEPES (pH = 7.2), 150 mM NaCl, 10% glycerol, 1.5 mmol/l MgCl2, 5 mM EGTA, 10 μg/ml aprotinin, 10 μg/ml leupeptin. 15 μg of total protein was electrophoresed on a 10 % SDS-PAGE gel. The proteins were then transferred to nitrocellulose membranes and probed with rabbit anti-GFP polyclonal antibody (JL-8, Clontech, Mountain View, CA) or rabbit polyclonal antibody against HIV-Tat peptide antibody (PA-2120-100, Innovagen, Lund, Sweden), followed by incubation with horseradish peroxidase-conjugated goat anti-rabbit antibody (Amersham Biosciences, Little Chalfont, UK). Enhanced chemiluminescence (ECL; Amersham) was used to detect bound antibody.

2.7 Cells and cell culture
HeLa cells (human cervical cancer cell line) were obtained from the Bio-resources Collection and Research Center of Taiwan (BCRC). The cells were cultured in RPMI 1640 medium supplemented with 10% (v/v) fetal bovine serum and antibiotics (80 mg/l penicillin and 100 mg/l streptomycin) in an incubator (Thermo Forma 3111, USA) at 37℃ under 5% CO2 in air. Cell culture media was replenished at 3-day intervals.

2.8 In-vitro internalization of recombinant proteins in mammalian cells
The internalization efficiency of Tat fusion protein was evaluated in human cervical cancer (HeLa) cell line. Cells were cultured in 24-well cell culture plates in RPMI 1640 medium, supplemented with 10% (v/v) fetal calf serum (FCS). The recombinant protein was subsequently added into the medium with a final concentration from 1 to 10 μM and incubated with cells for 3 hours. After incubation, cells were washed three times with cold PBS (pH 7.3) and fixed in 4% (v/v) formaldehyde in PBS for 10 minutes at room temperature. After the fixation, cells were washed three times with distilled water. Individual coverslips were mounted onto fresh glass slides. Cells were observed with a bright field, GFP channel, and merged channel, respectively, using a Leica fluorescence microscopy (AXTOSKOP-50, Germany). The excitation was set at 491 nm and the emission was set at 510 nm. The images were recorded with a digital camera. 
The internalization efficiencies of Tat-conjugated proteins were quantified using fluorescent flow cytometry (FACSC Caliber, BD, San Jose, CA, USA) with FL1 filters (excitation, 488 nm; emission, 532 nm). HeLa cells (1.0×106 cells/ml) were co-cultured with recombinant proteins for 3 hours. After removing the culture medium, the cells were collected and washed for three times by using PBS buffer, then treated with trypsin (1 g/L) for 15 min at 37℃ to remove any membrane-associated proteins bound to the cell surface. Finally, the cells were washed again with ice-cold PBS and re-suspended in 0.5 ml PBS and its fluorescence intensity at 488 nm was analyzed by flow cytometry.

2.9 Ex-vivo skin permeation of GST-Tat-GFP and GST-GFP-Tat by confocal microscopy 
To evaluate the skin penetration of GST-Tat-GFP and GST-GFP-Tat protein, redundant human skin from patients who had undergone abdominal plastic surgery was used. The subcutaneous fatty tissue was removed using a scalpel. Skin explants of 20 mm in diameter were punched out, sterilized in 70% alcohol for 10 seconds, rinsed in DMEM culture medium with antibiotics (Gibco, Paisley, England) 3 times and transferred onto a 6-well culture plate. Finally, skin explants were submerged into DMEM culture medium in presence of GST-GFP-Tat or GST-Tat-GFP at a final protein concentration of 20 μM, and cultured in the 5% CO2 incubator at 37℃ for up to 2 hours. At different endpoints of the penetration experiment (1, 2, 4 and 6 hours), 2mm punch biopsies were obtained from the center of skin explants with GST-GFP-Tat or GST-Tat-GFP pretreatment. The biopsies were snap frozen using liquid nitrogen, embedded in O.C.T. embedding medium (Tissue-Tek, Pelco International, USA), and sectioned (8 μm, perpendicular to the skin) using a cryostat microtome (Leica CM1900, German). The sections were visualized with a confocal microscope (Leica, TCS SP5, German) at a 20X objective, PMT 800 V, and eGFP filter set (ex 488nm / em 592nm).
For quantification of mean fluorescence, confocal images were analyzed by using ImageJ software. Identical regions of each image were measured for each application. ImageJ converts image pixels into brightness values (arbitrary units). Surface plots were developed and brightness values of all the images were measured and represented as mean fluorescence.

2.10 Statistical analysis. 
Statistical significance of the differences was determined by the two-tailed Studentt-test using Microsoft Excel software. P values < 0.05 were considered as statistically significant.

3. Results
3.1 Expression and purification of GST-Tat-GFP and GST-GFP-Tat proteins 
Green fluorescent protein (GFP) is a versatile and powerful tool for investigating of diverse biological processes. The characteristic properties of GFP make itself a perfect candidate for use as a fluorescence reporter to monitor patterns of protein localization, and intracellular protein trafficking in vivo. Three expression vectors pGEX-GFP, pGEX-TAT-GFP and pGEX-GFP-TAT were constructed which direct the high-efficiency expression of three fusion proteins under the control of the tac-promoter in Escherichia coli strain BL21 (Figure 1A). Each of these constructs was confirmed by restriction enzymes double digestion (Figure 1B). After 6 hours of IPTG induction at 25℃, strong green fluorescence was showed in the fermentation broth of all proteins, indicating the expression of GST-GFP, GST-Tat-GFP and GST-GFP-Tat was successful. The designed fusion gene strategy allows the convenient purification of soluble recombinant proteins to homogeneity with single-step glutathione-S-transferase (GST) affinity chromatography.


Figure 1. (A) Structures of plasmids used to express GST-GFP, GST-Tat-GFP and GST-GFP-Tat proteins. (B) Identification of recombinant plasmids of pGEX-GFP, pGEX-Tat-GFP and pGEX-GFP-Tat by restriction enzyme digestion. Lane M, DNA Marker; Lane 1, plasmid pGEX-Tat-GFP double digested by EcoR I and BamH I; Lane 2, plasmid pGEX- GFP-Tat double digested by EcoR I and BamH I; Lane 3, plasmid pGEX-GFP double digested by EcoR I and BamH I.





Figure 2. Identification of recombinant proteins of GST-GFP, GST-Tat-GFP and GST-GFP-Tat proteins. (A) Expression of the recombinant proteins in E.coli transformed with pGEX-GFP, pGEX-Tat-GFP and pGEX-GFP-Tat. Non-purified proteins from LB broth were separated on a 12.5 % SDS–PAGE gel and stained by Commassie blue. Lane M, protein markers; Lane 1, wild type GFP; Lane 2, GST-GFP; Lane 3, GST-Tat-GFP; Lane 4, GST-GFP-Tat. (B) Western blot analysis of purified proteins using polyclonal antibody against GFP. Lane 1, GST-Tat-GFP; Lane 2, GST-GFP-Tat; Lane 3, GST-GFP. (C) Western blot analysis of purified proteins using polyclonal antibody against Tat peptide. Lane 1, GST-Tat-GFP; Lane 2, GST-GFP-Tat; Lane 3, GST-GFP.

3.3 Comparison of internalization of GST-Tat-GFP and GST-GFP-Tat in HeLa cells by using fluorescence microscopy and flow cytometry
To assess whether the cellular internalization of cargo proteins can be enhanced by fusing a Tat peptide in the center of proteins, human cervical cancer (HeLa) cell was used. The cellular internalization of GST-Tat-GFP was examined by fluorescence microscopy and flow cytometry analysis in dose-response experiments at protein concentrations ranging from 1 to 10 μM for 3 hours at 37℃. GST-GFP-Tat and GST-GFP were used as positive and negative control. Before analysis, treated cells were rinsed with PBS buffer and incubated with trypsin (1 g/L) at 37℃ for 15 minutes to remove any membrane-associated protein. 

Imaging of live cells by fluorescence microscopy showed that the uptake of GST-Tat-GFP was barely visible above background with the protein concentration of 1μM (Figure 3A). When the concentration used was increased to 2 μM, visible amount of punctate surface staining began to emerge, indicating that the proteins were bound to the cellular membrane. Cytoplasmic diffuse staining was only observed under the highest concentration investigated of 10μM. In comparison, the uptake of GST-GFP-Tat was significantly higher than GST-Tat-GFP in HeLa cells with the same protein concentration used (Figure 3A). Visible amount of punctate surface staining was found from the lowest concentration investigated (1μM) while cytoplasmic diffuse staining was found from the concentration of 5μM. At the highest concentration investigated (10μM), both punctate and diffuse staining were significant in HeLa cells, whereas the punctate surface staining was much stronger than the cytoplasmic diffuse staining. Meanwhile, no fluorescence was observed in the cell surface or cytoplasm when cells were incubated with GST-GFP under all concentrations tested, suggesting no cellular internalization occurred in HeLa cells without fusing to a Tat peptide. It should be noted that extensive washing of the cells by PBS and trypsin did not result in removal of the punctate surface staining, suggesting that those GST-Tat-GFP and GST-GFP-Tat proteins bound to cell membrane did not dissociate under washing conditions used here (Data not shown).

The uptake efficiency was also examined by flow cytometry analysis, which allowed the quantification of fluorescent-positive cell population. As shown in Figure 3B, the cells treated with GST-Tat-GFP and GST-GFP-Tat both showed a shift toward increased green fluorescence signal, compared to the control cells treated with GST-GFP. A maximum cellular uptake efficiency was observed in both GST-GFP-Tat and GST-Tat-GFP with highest protein concentration used (10μM) after 3 hours of incubation. Approximately 80% HeLa cells treated with GST-GFP-Tat was found to be fluorescent-positive, compared to cells treated with GST-Tat-GFP in which only 22.9% cells were fluorescent-positive. Thus, the internalization efficiency of GST-GFP-Tat and GST-Tat-GFP is 50-fold and 14.3-fold higher than that of GST-GFP, respectively. Our fluorescence microscopy and flow cytometry data clearly indicated that the cellular internalization of GST-Tat-GFP with a Tat peptide fusing in the center of proteins was successful, whereas the internalization efficiency of GST-Tat-GFP was much lower than that of GST-GFP-Tat.

Figure 3. Cellular internalization of GST-Tat-GFP and GST-GFP-Tat protein in HeLa cells as determined by using fluorescence microscopy and flow cytometry. HeLa cells were treated with purified GST-GFP, GST-Tat-GFP and GST-GFP-Tat proteins at various concentrations from 1 to 10 μM for 3 hours at 37℃. Afterincubation, cells were rinsed with PBS buffer and then treated with trypsin (1 g/L) at 37℃ for 15 mins. Finally, cells were resuspended in PBS buffer, and subjected to flow cytometry. Data are expressed as mean ± S.E. based on three independent experiments with similar results.

3.6 Transdermal delivery of recombinant proteins in human skin
To investigate whether GST-Tat-GFP has the ability of penetrate stratum corneum (SC) and enter the deeper dermis, the ex-vivo skin permeability of GST-Tat-GFP and GST-GFP-Tat protein in human skin was evaluated and compared by using confocal microscopy. GST-GFP protein was also applied topically as a negative control. As expected, the treatment of skin explant with GST-GFP (20 μM) resulted in the signal of fluorescence predominantly localized on the surface of stratum corneum and no signal of fluorescence was observed in deeper epidermis and dermis at all time points investigated (Figure 4), indicating GST-GFP has no ability to penetrate stratum corneum. However, the skin explant treated with GST-Tat-GFP and GST-GFP-Tat (20 μM) revealed a strong green fluorescence throughout epidermis after 1 hour of topical application. When the application time was further increased to 2 hours, the signal of fluorescence in epidermis and dermis became stronger and deeper. A maximum transdermal delivery was observed in both GST-GFP-Tat and GST-Tat-GFP group after 6 hours of topical application (Figure 4). Quantitation by compiling data from two-dimensional surface plots indicated that the fluorescence intensity was 577.4 and 338.8 arbitrary units for GST-GFP-Tat and GST-Tat-GFP respectively. These ex-vivo results demonstrated that both GST-Tat-GFP and GST-GFP-Tat efficiently penetrated  SC, entered viable epidermis and reached deeper dermis, while GST-GFP without a Tat peptide fused was unable to penetrate SC. There is clear evidence that Tat peptide is capable of transporting cargo proteins through the skin when a Tat peptide is fused in the center of proteins. It was also noted that the skin permeability of GST-GFP-Tat with a Tat peptide terminal fused was much superior to GST-Tat-GFP with a Tat peptide central conjugated.


Figure 4. Ex-vivo skin permeability of GST-Tat-GFP and GST-GFP-Tat under various incubation periods as observed by using confocal microscopy. Left panel, pretreated with GST-GFP protein; Middle panel, pretreated with GST-Tat-GFP; Right panel, pretreated with GST-Tat-GFP protein. Sections were visualized using eGFP filter through a 20X objective. Scale bars are 50 μm. To quantify fluorescent images, the relative intensities after transdermal delivery were calculated by using the ImageJ software. Data are expressed as mean ± SD based on 6 replicates of three independent experiments. 

4. Discussion
Very few studies so far have reported that the cellular internalization of cargo proteins with a Tat peptide fusing in the center of proteins, as Tat peptide was normally fused to the C-terminus or N-terminus of proteins in most of previous studies [17-19]. It is highly questionable that whether the cellular internalization and transdermal delivery of cargo proteins can be enhanced by fusing a Tat peptide in the center of proteins. Rusnati et al. firstly reported that that the GFP and GST moieties on both ends of Tat peptide did not significantly interfere the cellular internalization, suggesting that the attraction between heparin oligosaccharides and Tat peptides was the key to the successful cellular uptake [17]. Tyagi et al. also demonstrated that the cell surface heparan sulfate (HS) proteoglycans, which are expressed in most cell types, are responsible for the efficient internalization of the GST-Tat-GFP protein [18]. Another study by Ferrari et al. reported that the GST-Tat-GFP successfully translocated into cells through a caveolar-mediated pathway and localized in the perinuclear region through actin-vehicled slow movements [19]. However, no comparative data on cargo proteins with a Tat peptide terminal fused and central conjugated was provided in all above studies. This is the first study we know, in which the cellular internalization and transdermal delivery of cargo proteins with a Tat peptide terminal fused and central conjugated were investigated and compared.

Our results from live cell experiments by using fluorescence microscopy and flow cytometry showed that GST-Tat-GFP protein can efficiently internalize into HeLa cells when a Tat peptide is fused in the center of proteins, whereas its efficiency is lower than that of GST-GFP-Tat protein with a Tat peptide terminal fused. Apart from the in-vitro cellular internalization capacity in live cells, the ex-vivo transdermal delivery data also showed that GST-Tat-GFP has lower efficiency to penetrate through human SC layer when compared with GST-GFP-Tat. What might be the reasons underlying the observed differences in cellular internalization between the GST-Tat-GFP and GST-GFP-Tat? We believe it might be due to the higher flexibility and mobility of Tat peptide in GST-GFP-Tat than those in GST-Tat-GFP. When a Tat peptide was conjugated in the center of proteins and it might be difficult to associate with cell membrane and/or environment. Thus, steric hindrance of cargo proteins fused on the both ends of Tat peptide could reduce the exposure of arginine residues to cell membrane and hydrophilic environment, subsequently leading to lower efficiency of cellular internalization. In fact, accumulating evidences are leading to a new theory that the guanidinium ions pairing between the arginine residues on Tat peptides and the phosphate moieties on lipid headgroups play a unique role in facilitating the internalization of Tat peptides, which is indirectly supporting our hypothesis [23-25]. A previous MD simulation study by MacCallum’s group demonstrated that the translocation of arginine molecules across lipid bilayer was accompanied by the formation of a water defect in lipid bilayer that can keep arginine molecules and lipid headgroups hydrated even at the hydrophobic center of lipid bilayer [26]. Li et al., also reported that any attempt to insert a single arginine deep into the hydrophobic core of lipid bilayer would severely distort the lipid membrane by opening a pore above it [27]. All these evidences are supporting that the exposure of arginine molecules to cell membrane and hydrophilic environment is essential for the efficient internalization of Tat-conjugated proteins.

Moreover, different distribution patterns of cellular internalization of GST-Tat-GFP and GST-GFP-Tat were found in HeLa cells under various protein concentrations investigated, suggesting independent mechanisms of internalization occurred. As punctate surface staining appeared first at low protein concentrations investigated and cytoplasmic diffuse staining emerged later at high protein concentrations investigated, we suggest that the Tat-conjugated proteins were first associated with cell membrane, then accumulated on the cell surface, and finally redistributed from the cell membrane to the cytoplasm under the time courses investigated. We believe that the main feature of Tat peptide is to mediate cell surface adherence, which has strongly implicated in our previous neutron diffraction study. Tat-conjugated molecules are likely to adhere and accumulate on the cell membrane via the multidentate hydrogen bonds formed between the guanidinium ions on arginine residues and the phosphate moieties on lipid headgroups [24]. The cell surface accumulation of Tat-conjugated proteins results in subsequent lipid membrane deformation and successful internalization.

Another intriguing question is raised by our findings that how Tat peptides facilitate the cellular internalization and transdermal delivery of cargo proteins when it is fused in the center of proteins? Despite of a lot of debate on the detailed mechanism of internalization, a common consensus has reached on that the internalization of Tat peptides might occur through distinct pathways in the same time, including energy-dependent endocytosis and energy-independent direct translocation [28-34]. In terms of the direct translocation mechanism recruited by Tat peptides, the pore formation mechanism has been strongly implicated by many recent studies. By using umbrella sampling calculations, Sun et al., has demonstrated that arginine-rich CPPs (ARG8) interacted with each other in a cooperative manner to prolong the life-time of transient pores presented in membrane, thereby facilitating the rapid translocation of peptides [35]. More intriguingly, they found a threshold concentration of surface-bound peptides was required for steady-state pores formation, which is in good agreement with our fluorescence microscopy observations. Additional support is from recent coarse-grained MD simulation by Hu et al., in which water pores formation was found in the DMPC/DMPS anionic lipid bilayer when the concentration of hexa-arginine peptide exceeded a critical value [36]. Combined with our observations in transdermal delivery study that GST-Tat-GFP could penetrate through stratum corneum, the outermost dead cell layer of skin, and deliver cargo proteins into the skin layers, therefore we exclude the possibility of the energy-dependent endocytosis pathway and suggest the pore formation mechanism. 

Indeed, above assumption is convincingly supported by our previous observation by neutron diffraction experiments in which Tat peptides interacted with phospholipid bilayers [23, 24]. Firstly, a limited number of Tat-conjugated proteins interact with lipid headgroups by using the intrinsic guanidinium ions pairing between the arginine residues on Tat peptides and the phosphate moieties on lipid headgroups. While more Tat-conjugated proteins were attracted on the surface of lipid bilayer, significant bilayer deformations would happen. Once a critical threshold concentration of Tat-conjugated proteins accumulated on the outer layer of bilayer was reached, the final event of internalization of Tat-conjugated proteins would be triggered. Conceivably, only the formation of steady-state water pores in cell membrane can satisfactorily explain the successful internalization of large Tat-conjugated protein like GST-Tat-GFP and GST-GFP-Tat.

Conclusion
In summary, the present study demonstrated that the cellular internalization of GST-Tat-GFP in HeLa cells was successful, as well as the transdermal delivery of GST-Tat-GFP in human skin. However, GST-Tat-GFP showed lower penetration capacity in both the cellular internalization and transdermal delivery, as compared with GST-GFP-Tat. In HeLa cell experiments, both GST-GFP-Tat and GST-Tat-GFP showed a various degree of a mixture of cytoplasmic diffuse staining and punctate surface staining, and that the distribution pattern varied considerably depending on the concentration of protein used. Our findings suggest that Tat peptides mediated cell surface adherence and accumulation, a property shared with many other arginine-rich peptides. Therefore, an improved mechanism for Tat-conjugated proteins was proposed. Tat-conjugated proteins were first associated with cell membrane, then accumulated on cell surface, and finally internalized into cells by a pore formation mechanism. Our current data implicates that the flexibility of conjugating a Tat peptide with cargo proteins for the enhancement of in-vivo delivery and the potential for a wide range of biopharmaceutical applications.
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